Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/118743
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPöttgen, Simon-
dc.contributor.authorMazurek-Budzyńska, Magdalena-
dc.contributor.authorWischke, Christian-
dc.date.accessioned2025-04-07T06:56:06Z-
dc.date.available2025-04-07T06:56:06Z-
dc.date.issued2025-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/120701-
dc.identifier.urihttp://dx.doi.org/10.25673/118743-
dc.description.abstractPolymer microparticles are a cornerstone in the field of injectable sustained delivery systems: They allow the entrapment of various types of hydrophobic or hydrophilic drugs including biopharmaceuticals. Microparticles can be prepared from the material of choice and tailored to specific target sizes. Importantly, they can retain the drug at the local administration site to achieve a sustained drug release for long-term therapeutic effects. This review focuses on the role of porosity of microparticles as a tremendously important property. Principles to prepare porous carriers via different techniques and additives are discussed, emphasizing that porosity is not a static property but can be dynamic, e.g., for particles from polylactide or poly(lactide-co-glycolide). Considering the contribution of porosity in the overall assessment of drug carrier systems, as well as their manipulation/alteration post-production such as by pore closing, will enlarge the understanding of polymer microparticles as an important class of modern pharmaceutical dosage forms.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.subject.ddc615-
dc.titleThe role of porosity in polyester microparticles for drug deliveryeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleInternational journal of pharmaceutics-
local.bibliographicCitation.volume672-
local.bibliographicCitation.publishernameElsevier-
local.bibliographicCitation.publisherplaceNew York, NY [u.a.]-
local.bibliographicCitation.doi10.1016/j.ijpharm.2025.125340-
local.openaccesstrue-
dc.identifier.ppn191895447X-
cbs.publication.displayform2025-
local.bibliographicCitation.year2025-
cbs.sru.importDate2025-04-07T06:55:40Z-
local.bibliographicCitationEnthalten in International journal of pharmaceutics - New York, NY [u.a.] : Elsevier, 1978-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
1-s2.0-S0378517325001760-main.pdf21.16 MBAdobe PDFThumbnail
View/Open